ERLANGER Home
MyErlangerHealth HealthLink Plus For Vendors For the Media Physician Relations and Recruitment
975 East Third Street
Chattanooga, TN 37403
423-778-7000
Children's Hospital at Erlanger Erlanger Baroness Campus Erlanger Bledsoe Campus Erlanger East Campus Erlanger North Campus UT Erlanger Physicians Group





Online Prereg
Register for a Class or Event
New Foundations Page
Print   Email

Head & Neck

Head and Neck Cancer Studies

 E1305                               Principal Investigator: Larry Schlabach, MD

                                                Co-Investigator: John McCravey, MD and Matt Graham, MD

Title: A Phase III Randomised Trial of chemotherapy With or WithoutBevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer. (IRB#: 08-106)

NCT #: NCT00588770        Phase: Phase III

Purpose:This randomized phase III trial is studying chemotherapy to see how well it works with or without bevacizumab in treating patients with recurrent or metastatic head and neck cancer. 

Drugs possibly given:
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil

Please view complete information about this trial at: http://www.clinicaltrial.gov/ct2/show/NCT00588770?term=E1305&rank=1

Erlanger Institute for Clinical Research
975 East 3rd Street
Suite B-1203
Chattanooga, TN 37403

423-778-3900

Monday – Friday
8:00 a.m. – 4:00 p.m.


Need directions?
Enter your address
(example: 555 Main St, Chattanooga, TN)


RELATED LINKS

What is a Clinical Trial?

Should I take part in a Clinical Trial?

How do I take part in a Clinical Trial?

Questions to ask your doctor.

How is a clinical trial planned and carried out?

Contact Information for Clinical Trials at Erlanger.

Source: NCI.NIH.gov, ClinicalTrials.gov